Recent News

521 News Items found
Pictured: Christopher Lima
Honors
Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.
Pictured: Charles Sawyers
In the Lab
Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.
Pictured: Alexandria Miller
Six students have successfully defended their dissertations and will receive their PhD degrees at Commencement on May 10.
Pictured: Kenneth Offit
Finding
A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.
In the Clinic
Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
Pictured: ESK1 Monoclonal Antibody
In the Lab
Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
Pictured: Charles Sawyers
Honors
Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.
Pictured: Neurons
In the Lab
Researchers have clarified the process by which developing nerve cells are directed to specialize into distinct parts.
Pictured: X-ray Image
In the Lab
Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
Pictured: Ming Li
Q&A
Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.